Cardinal Health Inc.CAH
Close of Friday, October 23, 2026 · Cardinal Health Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$249.59
vs its Pivot
+12.9%
OnlyAlpha Score
70
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +12.4% | +22.6% | +57.9% | +40.6% | +41.6% |
Dividend: $2.05 a share over the last 12 months, a 0.82% yield at today's price. A Dividend Aristocrat.
Who runs and owns it
In these funds
Suppliers, customers and partners
Sells to CAH
| Eli Lilly | significant % of revenue each (XBRL: 16-24% each) |
| AbbVie | substantially all US sales combined; none >43% |
| Amgen | >10% of revenue each; 77% of gross rev combined |
| Gilead Sciences | ~90% of US gross sales combined |
| Halozyme | wholesale distributor (XYOSTED) |
| Embecta | three largest distributors; ~42% of gross sales combined |
| Amphastar Pharmaceuticals | 19% of net revenues |
| Amneal Pharmaceuticals | top-4 customers; ~71% of net revenue combined |
CAH sells to
| CVS Health | 28% of revenue |
| Vizient (GPO, private) | GPO members; 29% combined w/ Premier |
| Premier Inc. (GPO) | GPO members; 29% combined w/ Vizient |
Partners and deals
| CVS Health | Red Oak Sourcing (50/50) |
From the companies' own annual reports filed with the SEC.
Healthcare · Drug distributors and pharmacies
Get CAH in your free daily emailAfter every close: whether CAH is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track CAH free → Full Stock check
Track CAH free → Full Stock check